Controversies in the management of the anemia of prematurity using single-donor red blood cell transfusions and/or recombinant human erythropoietin

Transfusion Medicine Reviews

Volumn 20, Issue 1, 2006, Pages 34-44

  Strauss, Ronald G ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT ERYTHROPOIETIN;

ANEMIA; BLOOD DONOR; BLOOD TRANSFUSION; CHILD DEATH; CLINICAL TRIAL; CRITICAL ILLNESS; DISEASE SEVERITY; ERYTHROCYTE; ERYTHROPOIESIS; HUMAN; INFORMATION PROCESSING; MEDICAL LITERATURE; META ANALYSIS; PRACTICE GUIDELINE; RETINOPATHY; REVIEW; SIDE EFFECT; SYSTEMATIC REVIEW;

EID: 29144447744     PISSN: 08877963     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tmrv.2005.08.003     Document Type: Article

References (42)

1. R.G. Strauss Data-driven blood banking practices for neonatal RBC transfusions Transfusion 40 2000 1528 1540
2. J.A. Widness, V.J. Seward, and I.J. Kromer Changing patterns of red blood cell transfusion in very low birthweight infants J. Pediatr. 129 1996 680 687
3. R.G. Strauss, P.J. Villhauer, and D.G. Cordle A method to collect, store and issue multiple aliquots of packed red blood cells for neonatal transfusions Vox Sang. 68 1995 77 81
4. R.G. Strauss, L.F. Burmeister, and K. Johnson AS-1 red blood cells for neonatal transfusions: A randomized trial assessing donor exposure and safety Transfusion 36 1996 873 878
5. R.G. Strauss, L.F. Burmeister, and K. Johnson Feasibility and safety of AS-3 red blood cells for neonatal transfusions J. Pediatr. 136 2000 215 219
6. N.L.C. Luban, R.G. Strauss, and H.A. Hume Commentary on the safety of red blood cells preserved in extended storage media for neonatal transfusions Transfusion 31 1991 229 235
7. E.A. Liu, F.L. Mannino, and T.A. Lane Prospective, randomized trial of the safety and efficacy of a limited donor exposure transfusion program for premature neonates J. Pediatr. 125 1994 92 96
8. D.A. Lee, T.A. Slagel, and T.M. Jackson Reducing blood donor exposures in low birth weight infants by the use of older, unwashed packed red blood cells J. Pediatr. 126 1995 280 286
9. S. Cook, J. Gunter, and M. Wissel Effective use of a strategy using assigned red cell units to limit donor exposure for neonatal patients Transfusion 33 1993 379 383
10. R. Jain, C.R. Jarosz, and T.F. Myers Decreasing blood donor exposure in the neonates by using dedicated donor transfusions Transfus. Sci. 18 1997 199 203
11. A. Wood, N. Wilson, and P. Skacel Reducing donor exposure in preterm infants requiring multiple blood transfusions Arch. Dis. Child. 72 1995 F29 F33
12. R. Jain, and C. Jarosz Safety and efficacy of AS-1 red blood cell use in neonates Transfus. Apher. Sci. 24 2001 111 115
13. P.W. Soothill, A.N. Lestas, and K.H. Nicolaides 2,3-diphosphoglycerate in normal, anaemic and transfused human fetuses Clin. Sci. 74 1988 527 530
14. M. DeLivoria-Papadopoulos, G. Morrow, and F.A. Oski Exchange transfusion in the newborn infant with fresh and "old" blood: The role of storage on a 2,3-diphosphoglycerate, hemoglobin-oxygen affinity, and oxygen release J. Pediatr. 79 1971 898 903
15. P. Hilsenrath, J. Nemechek, and J.A. Widness Cost-effectiveness of a limited donor blood program for neonatal RBC transfusions Transfusion 39 1999 938 943
16. J. Wang-Rodriguez, F.L. Mannino, and E. Liu A novel strategy to limit blood donor exposure and blood waste in multiply transfused premature infants Transfusion 36 1996 64 70
17. T.A. Louis Meta-analysis of clinical studies: The whole is greater than the sum of its parts Transfusion 33 1993 670 698
18. R.G. Strauss Current issues in neonatal transfusions Vox Sang. 51 1986 1 9
19. J.A. Stockman Anemia of prematurity. Current concepts in the issue of when to transfuse Pediatr. Clin. North Am. 33 1986 111 128
20. R.G. Strauss, D.M. Mock, and J.A. Widness Post-transfusion 24-hour recovery and subsequent survival of allogeneic red blood cells in the bloodstream of newborn infants Transfusion 44 2004 871 876
21. M.S. Brown, R.H. Phibbs, and J.F. Garcia Postnatal changes in erythropoietin levels in untransfused premature infants J. Pediatr. 103 1983 612 617
22. R.G. Strauss Managing the anemia of prematurity: Red blood cell transfusions versus recombinant erythropoietin Transf. Med. Rev. 15 2001 213 223
23. J.A. Widness, and R.G. Strauss Recombinant erythropoietin in the treatment of the premature newborn Semin. Neonatal. 3 1998 163 171
24. J.A. Wilimas, and W.M. Crist Erythropoietin-not yet a standard treatment for anemia of prematurity Pediatrics 95 1995 9 10
25. J.J. Doyle The role of erythropoietin in the anemia of prematurity Sem. Perinatol. 21 1997 20 27
26. E.C. Vamvakas, and R.G. Strauss Meta-analysis of controlled clinical trials studying the efficacy of recombinant human erythropoietin in reducing blood transfusions in the anemia of prematurity Transfusion 41 2001 406 415
27. K.M. Shannon, J.F. Keith III, and W.C. Mentzer Recombinant human erythropoietin stimulates erythropoiesis and reduces erythrocyte transfusions in very-low-birth-weight preterm infants Pediatrics 95 1995 1 8
28. R.K. Ohls, J. Harcum, and K.R. Schibler The effect of erythropoietin on the transfusion requirements of preterm infants weighing 750 grams or less: A randomized, double-blind, placebo-controlled trial J. Pediatr. 131 1997 661 665
29. P. Kumar, S. Shankaran, and R.G. Krishnan Recombinant human erythropoietin therapy for treatment of anemia of prematurity in very-low-birth-weight infants: A randomized, double-blind, placebo-controlled trial J. Perinatol. 18 1998 173 177
30. R.K. Ohls, R.A. Ehrenkranz, and J.A. Lemons A multicenter randomized double-masked placebo-controlled trial of early erythropoietin and iron administration to preterm infants Pediatrics 108 2001 934 942
31. C. Romagnoli, E. Zecca, and F. Gallini Do recombinant human erythropoietin and iron supplementation increase the risk of retinopathy of prematurity? Eur. J. Pediatr. 159 2000 627 634
32. S.E. Juul, A.T. Yachnis, and R.D. Christensen Tissue distribution of erythropoietin and erythropoietin receptor in the developing human fetus Early Hum. Dev. 52 1998 235 249
33. S.E. Juul, S.A. Stallings, and R.D. Christensen Erythropoietin in the cerebrospinal fluid of neonates who sustained CNS injury Pediatr. Res. 46 1999 543 547
34. A. Pollak, M. Hayde, and M. Hayn Effect of intravenous iron supplementation on erythropoiesis in erythropoietin-treated premature infants Pediatrics 107 2001 78 85
35. M. Akisu, S. Tuzun, and S. Arslanoglu Effect of recombinant human erythropoietin administration on lipid peroxidation and antioxidant enzymes(s) activities in preterm infants Acta Med. Okayama 55 2001 357 362
36. H. Donato, N. Vain, and P. Rendo Effect of early versus late administration of human recombinant erythropoietin on transfusion requirements in premature infants: Results of a randomized, placebo-controlled, multicenter trial Pediatrics 105 2000 1066 1072
37. C.L. Yeo, S. Choo, and L.Y. Ho Effect of recombinant human erythropoietin on transfusion needs in preterm infants J. Paediatr. Child Health 37 2001 352 358
38. M.P. Meyer, E. Sharma, and M. Carsons Recombinant erythropoietin and blood transfusion in selected preterm infants Arch. Dis. Child. Fetal Neonatal Ed. 88 2003 F41 F45
39. R.E. Maier, M. Obladen, and I. Müller-Hansen Early treatment with erythropoietin b ameliorates anemia and reduces transfusion requirements in infants with birth weights below 1000 g J. Pediatr. 141 2002 8 15
40. M. Avent, B.J. Cory, and J. Galpin A comparison of high versus low dose recombinant human erythropoietin versus blood transfusion in the management of anemia of prematurity in a developing country J. Trop. Pediatr. 48 2002 227 233
41. A.R. Franz, and F. Pohlandt Red blood cell transfusions in very and extremely low birthweight infants under restrictive transfusion guidelines: Is exogenous erythropoietin necessary? Arch. Dis. Child. Fetal Neonatal Ed. 84 2001 F96 F100
42. A.A. Amin, and D.M. Alzahrani Efficacy of erythropoietin in premature infants Saudi Med. J. 23 2002 287 290